Screening compound: C19H25N5O4S2 (L507-2507)

Screening compound: C<sub>19</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> (L507-2507)
Screening compound: C<sub>19</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> (L507-2507) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C19H25N5O4S2 (L507-2507)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L507-2507

Molecular Formula

C19H25N5O4S2 (C19 H25 N5 O4 S2)

Compound Name

2-{1,5-dimethyl-4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]-1H-pyrrol-2-yl}-N,N-diethyl-4-methyl-1,3-thiazole-5-carboxamide

IUPAC name

2-{15-dimethyl-4-[(5-methyl-12-oxazol-3-yl)sulfamoyl]-1H-pyrrol-2-yl}-NN-diethyl-4-methyl-13-thiazole-5-carboxamide

SMILES

CCN(CC)C(c1c(C)nc(-c2cc(S(Nc3noc(C)c3)(=O)=O)c(C)n2C)s1)=O

InChI

InChI=1S/C19H25N5O4S2/c1-7-24(8-2)19(25)17-12(4)20-18(29-17)14-10-15(13(5)23(14)6)30(26,27)22-16-9-11(3)28-21-16/h9-10H,7-8H2,1-6H3,(H,21,22)

InChI Key

VWDBTFOEIWCBRD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27459559

C19H25N5O4S2 (L507-2507) in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

KRAS-Targeted Library (16000 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
  • Others
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C19H25N5O4S2 (L507-2507) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C19H25N5O4S2 (L507-2507)?
Check Price and Availability of C19H25N5O4S2 (L507-2507), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C19H25N5O4S2 (L507-2507) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C19H25N5O4S2 (L507-2507)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C19H25N5O4S2 (L507-2507)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C19H25N5O4S2 (L507-2507) available by request